Kelley L. Julian, PharmD, BCOP, discusses optimizing MM care, addressing barriers in access to intravenous immunoglobulin and innovative therapies at Huntsman Cancer Institute.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback